Literature DB >> 33589108

Rheumatoid Arthritis: Early Diagnosis and Treatment.

John J Cush1.   

Abstract

Rheumatoid arthritis (RA) is a chronic, progressive inflammatory disorder that manifests as a symmetric polyarthritis of small and large joints that may lead to joint and periarticular structural damage and the consequences of systemic inflammation. This overview of early RA examines the unmet needs and challenges in RA, how to best diagnose RA, and pitfalls in early diagnosis and treatment. The rules for referral to a rheumatologist are reviewed. Primary care physicians are at the front line of early diagnosis and need to start disease-modifying therapy as soon as a diagnosis of RA is established.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Early rheumatoid arthritis; Referral; Rheumatoid factor

Mesh:

Year:  2021        PMID: 33589108     DOI: 10.1016/j.mcna.2020.10.006

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  8 in total

1.  Tumor necrosis factor-alpha stimulated gene-6: A biomarker reflecting disease activity in rheumatoid arthritis.

Authors:  Tingting Hu; Yuhan Liu; Xu Li; Xiaohang Li; Yanzhao Liu; Qunxia Wang; Jiayi Huang; Jianlin Yu; Yang Wu; Simei Chen; Tingting Zeng; Liming Tan
Journal:  J Clin Lab Anal       Date:  2022-03-30       Impact factor: 3.124

2.  Needle-Warming Moxibustion plus Multirehabilitation Training to Improve Quality of Life and Functional Mobility of Patients with Rheumatoid Arthritis after Medication.

Authors:  Feng Wu; Manwei Huang; Lili Zeng; Zhihua Huang; Jinqing Zheng
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-20       Impact factor: 2.650

3.  Measurement of synovium and serum dual specificity phosphatase 22 level: Their inter-correlation and potency as biomarkers in rheumatoid arthritis.

Authors:  Chen Qian; Jie Chen; Xiaopeng Xu; Qingyang Liu; Minhong Gu; Sheng Lu; Hongxia Bai; Qiubo Wang; Mingyu Xue
Journal:  J Clin Lab Anal       Date:  2021-11-22       Impact factor: 2.352

Review 4.  Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives.

Authors:  Oskar Ciesielski; Marta Biesiekierska; Baptiste Panthu; Mirosław Soszyński; Luciano Pirola; Aneta Balcerczyk
Journal:  Cell Mol Life Sci       Date:  2022-01-25       Impact factor: 9.261

Review 5.  Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics.

Authors:  Shuo Wang; Biyu Lei; E Zhang; Puyang Gong; Jian Gu; Lili He; Lu Han; Zhixiang Yuan
Journal:  Int J Nanomedicine       Date:  2022-04-19

Review 6.  Pleiotropic Effects of Isoflavones in Inflammation and Chronic Degenerative Diseases.

Authors:  Jurga Bernatoniene; Jurga Andreja Kazlauskaite; Dalia Marija Kopustinskiene
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

Review 7.  Recent Findings on Thymoquinone and Its Applications as a Nanocarrier for the Treatment of Cancer and Rheumatoid Arthritis.

Authors:  Ravi Raj Pal; Vasundhara Rajpal; Priya Singh; Shubhini A Saraf
Journal:  Pharmaceutics       Date:  2021-05-22       Impact factor: 6.321

8.  Dextran sulfate-based MMP-2 enzyme-sensitive SR-A receptor targeting nanomicelles for the treatment of rheumatoid arthritis.

Authors:  Caiwei Yu; Hui Liu; Chunjing Guo; Qiang Chen; Yanguo Su; Huimin Guo; Xiaoya Hou; Feng Zhao; Huaying Fan; Hui Xu; Yan Zhao; Xiaofeng Mu; Guohua Wang; Haiyu Xu; Daquan Chen
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.